comparemela.com

Latest Breaking News On - Shelly vandertie - Page 1 : comparemela.com

Viracta Therapeutics Strengthens Company Leadership with New Appointments to the Board of Directors and Management Team

Viracta Therapeutics Strengthens Company Leadership with New Appointments to the Board of Directors and Management Team Stephen Rubino, Ph.D., MBA and Barry J. Simon, M.D. appointed to the Board of Directors Cheryl A. Madsen, RAC appointed as Senior Vice President, Regulatory Affairs News provided by Share this article Share this article SAN DIEGO, March 4, 2021 /PRNewswire/  Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that it has strengthened its leadership team with the appointments of Drs. Stephen Rubino and Barry J. Simon to the Board of Directors, the addition of Cheryl A. Madsen, RAC as Senior Vice President, Regulatory Affairs, and the promotion of several members of the management team.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.